Noticias April 03, 2021 Transforming cardiovascular treatment for the transgender population The Women's Heart Clinic and Transgender and Intersex Specialty Care Clinic at Mayo Clinic partner to provide assessment of the cardiovascular risk of gender-affirming surgery. April 03, 2021 Pediatric tracheal surgery: A multidisciplinary team approach to management At Mayo Clinic, the current techniques of simultaneous tracheal and cardiac repairs have yielded excellent early and late results for pediatric patients requiring tracheal surgery. Dec. 08, 2020 Advanced heart failure complexities and when to refer for specialty care Daniel S. Yip, M.D., responds to questions about challenges in pinpointing a patient's heart failure status and when cardiologists might consider referral for advanced heart failure care. Dec. 01, 2020 Statins can save lives, are they being used? ROCHESTER, Minn. ? People who have coronary artery disease, stroke or peripheral artery disease often are prescribed a statin, a cholesterol-lowering drug that reduces the risk of heart attack or stroke. In a recent public[...] Nov. 26, 2020 Drug use impacts the care required by patients with infective endocarditis A study of nearly 35,000 heart valve surgeries indicates that in some regions of the U.S., drug use-associated infective endocarditis now constitutes a majority of infective endocarditis valve surgeries. Nov. 26, 2020 TAILOR-PCI narrowly misses primary goal but indicates intriguing trends The TAILOR-PCI trial explores whether anti-platelet therapy guided by CYP2C19 genetic metabolizer status could reduce the incidence of ischemic events after percutaneous coronary intervention. Nov. 26, 2020 Congenital cardiac surgery: What's next? Mayo Clinic's congenital cardiac surgery specialists provide corrective care for many patients with congenital heart disease. These patients live with an excellent quality of life into adulthood. Nov. 20, 2020 Blood clots in the heart are common in patients with COVID-19 ROCHESTER, Minn. -- Researchers continue to study the effects of COVID-19 on the heart, including myocarditis -- a focused inflammation of the heart muscle. New research from Mayo Clinic suggests that myocarditis might not[...] Oct. 03, 2020 MitraClip treatment of mitral regurgitation after cardiac transplant: Case report A 72-year-old male who underwent orthotopic cardiac transplantation received MitraClip placement for severe mitral regurgitation, with almost complete resolution of symptoms within weeks of implantation. Oct. 03, 2020 Genetic testing reveals cause of mysterious deaths in Amish children Molecular autopsy employs genetic testing to understand the cause of sudden death and better predict risk for surviving family members. Oct. 03, 2020 New and novel treatments for hyperlipidemia Clinical outcome trials study the use of human monoclonal antibodies to target biochemical pathways that impact LDL receptor availability and monoclonal antibodies to block the PCSK-9 protein. Aug. 31, 2020 Mayo Clinic Q&A podcast: Heart muscle damage from COVID-19 From the beginning of the COVID-19 pandemic, it was known that the disease affected the lungs. But some of the most severe damage to the body can be to the heart muscle. COVID-related myocarditis, or inflammation of the he[...] Aug. 21, 2020 Cardio-oncology — A marriage of cardiology & oncology With more cancer drug options and increased treatment success, patients with cancer are surviving in record numbers. To address negative side effects of therapies on the heart and vascular function, Mayo Clinic establis[...] March 04, 2020 New evidence supports ablation for heart failure patients with atrial fibrillation ROCHESTER, Minn. -- Only 1 in 13 everyday patients could have participated in a pivotal international clinical trial looking at the use of catheter ablation to treat atrial fibrillation (AFib) among people with heart failu[...] Feb. 18, 2020 Mayo researchers create, test AI to improve EKG testing for hypertrophic cardiomyopathy ROCHESTER, Minn. ? An approach based on artificial intelligence (AI) may allow EKGs to be used to screen for hypertrophic cardiomyopathy in the future. With hypertrophic cardiomyopathy, the heart walls become thick and may[...] Feb. 18, 2020 How AI helps people with atrial fibrillation Atrial fibrillation is an irregular and often rapid heart rate that can increase your risk of stroke and other heart-related complications. Up to 6.1 million people in the U.S. have the condition, according to the Centers [...] Feb. 14, 2020 Mayo Clinic study looks at changes in patient characteristics, outcomes for coronary revascularization ROCHESTER, Minn. ? The most common type of heart disease ? coronary artery disease ? affects 6.7% of adults and accounts for 20% of deaths of adults under age 65. The condition builds over time as inflammation and choleste[...] Feb. 04, 2020 Earlier detection of women's vascular health issues can affect heart disease risk, Mayo Clinic study advises ROCHESTER, Minn. ? Men and women differ in the way their vascular systems age and the rate at which atherosclerosis ? the hardening of artery walls or buildup of arterial blockage ? progresses over time. These sex- and age[...] Feb. 01, 2020 Modified immunosuppressive regimen improves survival in heart transplant patients Retrospective research shows that early conversion from a calcineurin inhibitor-based regimen to sirolimus lowers rates of cardiac allograft vasculopathy and malignancy in heart transplant recipients. Feb. 01, 2020 Earlier intervention may improve outcomes in patients with aortic valve regurgitation Researchers report that patients had a higher mortality once they developed symptoms, and aortic valve surgery should be considered at an earlier stage of left ventricular enlargement. Feb. 01, 2020 Does reduction in red meat consumption improve health? Mayo specialists who reviewed recent studies from the NutriRECS consortium recommend, based on the totality of trial evidence, continuing to adhere to current dietary guidelines. Nov. 27, 2019 Managing pediatric supraventricular tachycardia Advances in ablation technology yield a 95% to 98% success rate and a less than 1% incidence of complications for pediatric patients treated for supraventricular tachycardia. Nov. 27, 2019 Post-Fontan operation pregnancy outcomes A Mayo Clinic analysis suggests Fontan physiology may not be compatible with good placental health. Nov. 27, 2019 Heart Brain Clinic targets cryptogenic stroke The Mayo Clinic Heart Brain Clinic is a leading collaborative specialty care model for managing and preventing cryptogenic strokes. Oct. 31, 2019 Common early sign of cardiovascular disease also may indicate cancer risk, study finds ROCHESTER, Minn. -- A Mayo Clinic-led study involving 488 cardiac patients whose cases were followed for up to 12 years finds that microvascular endothelial dysfunction, a common early sign of cardiovascular disease, is as[...] Oct. 23, 2019 Chronic kidney disease patients at increased risk of adverse cardiovascular outcomes, Mayo Clinic study finds ROCHESTER, Minn. -- Chronic kidney disease, which afflicts an estimated 6.4% of U.S. adults 45 and older, is associated with an increased risk of heart attack and other adverse cardiovascular outcomes, according to new res[...] Sept. 27, 2019 Use of sirolimus associated with a reduction in mortality risk after late post-heart transplantation Researchers report a reduced incidence of overall de novo malignancies (excluding nonmelanoma skin cancers) and post-transplantation lymphoproliferative disorders in recipients of heart transplantation who were converte[...] Sept. 18, 2019 Expert Alert: Study finds repeat coronary artery bypass grafting improves long-term survival ROCHESTER, Minn. ?-- When a coronary artery bypass grafting (CABG) patient needs a second surgery because of recurrent chest pain, more often than not it's a percutaneous coronary intervention (PCI), commonly known as coro[...] Sept. 01, 2019 Dog ownership and cardiovascular health: Results from the Kardiovise 2030 Project Project results indicate that, except for smoking, dog owners were more likely to achieve the recommended level of behavioral cardiovascular health metrics (physical activity and diet) than non-dog owners. Aug. 03, 2019 Cone reconstruction for Ebstein anomaly Mayo Clinic heart surgeons pioneered the cone reconstruction technique to correct Ebstein anomaly. Outcome data shows the technique is safe, durable and effective. Aug. 03, 2019 Pulmonary valve replacement the optimal treatment for asymptomatic patient with repaired tetralogy of Fallot Mayo Clinic cardiologists determined pulmonary valve replacement was the appropriate treatment for a 32-year-old, asymptomatic patient with a history of tetralogy of Fallot and severe pulmonary regurgitation. Aug. 01, 2019 Mayo Clinic study shows AI could enable accurate, inexpensive screening for atrial fibrillation ROCHESTER, Minn. -- A new Mayo Clinic research study shows that artificial intelligence (AI) can detect the signs of an irregular heart rhythm -- atrial fibrillation (AF) -- in an EKG, even if the heart is in normal [...] June 19, 2019 Study finds similar cardiovascular outcomes for generic, brand-name drugs for hypothyroidism JACKSONVILLE, Fla. -- A new study by Mayo Clinic researchers may have broad implications for treatment of patients with predominantly benign thyroid disease and newly treated hypothyroidism. The study, to be published in M[...] June 01, 2019 Developing augmented and virtual reality treatments Mayo Clinic is rapidly developing augmented and virtual reality ― artificial intelligence technologies ― to improve heart visualizations and create biopatches for arrhythmia therapy. June 01, 2019 Coronary anomaly clinic at Mayo Clinic A specialized subclinic of clinical cardiologists, cardiac imaging specialists and cardiovascular surgeons is devoted to the care and understanding of anomalies of the coronary arteries. June 01, 2019 Myocarditis biomarker predicts severity A research collaboration led by Mayo Clinic investigators identified the first biomarker for myocarditis, sera soluble ST2, and found it significantly elevated in men ≤ 50 years, compared with healthy controls and wo[...] June 01, 2019 Concomitant mitral valve intervention may increase risk for patients with hypertrophic cardiomyopathy undergoing septal myectomy A retrospective study supports the need for increasing surgical experience with septal myectomy for obstructive hypertrophic cardiomyopathy to further improve outcomes. June 01, 2019 Artificial intelligence-enabled ECG screening for asymptomatic left ventricular dysfunction Mayo researchers use convolutional neural networks to analyze electrocardiograms for silent subclinical, metabolic or structural abnormalities that may predict the presence of asymptomatic left ventricular dysfunction. June 01, 2019 Broadening the perspective for regeneration in the heart Mayo Clinic's cardiopoietic stem cell experience has created a team with unique expertise in product development, manufacturing, quality assurance and FDA-regulated clinical trial execution that advances regenerative me[...] April 15, 2019 Culturally relevant health app shows positive impact Fifty African American adults participated in a 10-week study that included podcasts and multimedia educational modules delivered via app. Results show several objectively measured positive outcomes for cardiovascular h[...] March 29, 2019 New ATTR amyloidosis treatment Amyloidosis is a disease of protein misfolding once considered rare, and increasingly implicated in heart failure. One form affecting the heart is transthyretin (ATTR) amyloidosis, for which treatment options are rapidl[...] March 29, 2019 Smart textiles embed monitoring Expertise in artificial intelligence-enabled health care powers Mayo Clinic algorithms for heart monitoring and arrhythmia detection that are embedded into textiles to improve care through wearable technology. Feb. 13, 2019 New tool predicts myocarditis-related heart failure in men Researchers found elevated levels of a protein in the blood, soluble ST2, to be a predictor of heart failure in men under 50 with myocarditis. Feb. 01, 2019 Artificial intelligence and contractile dysfunction At Mayo Clinic, interdisciplinary teams within Cardiovascular Medicine apply artificial intelligence (AI) techniques to develop a new screening tool for asymptomatic left ventricle dysfunction. Feb. 01, 2019 3D printing: The next dimension in cardiac imaging Mayo specialists use 3D printing to plan, explain and manage treatment for patients with congenital heart disease and teach complex cardiac anatomy effectively. Feb. 01, 2019 Congenital heart disease: The first 50 years … the next 50 years Congenital heart disease interventions are evolving due to the adult congenital heart disease subspecialty, improvement in transcatheter valve prostheses and imaging techniques, demand for cardiac replacement, and stem [...] Dec. 12, 2018 High-sensitivity troponin assay promises novel uses in managing patients with chronic heart disease FDA-approved assays T Gen 5 and hsTnI detect even the smallest rise in troponin levels, allowing for faster recognition of acute myocardial infarction and heart attack. Dec. 05, 2018 Innovative management strategy for a fetus with hypoplastic left heart syndrome and intact atrial septum Mayo pediatric cardiologists have used an ex utero intrapartum treatment (EXIT) procedure without cardiopulmonary bypass for an open-heart operation. The novel, sequential approach provides a promising strategy for mana[...] Nov. 08, 2018 Animal model suggests metabolic syndrome may impair repair Research indicates that mesenchymal stem cells in pigs with metabolic syndrome are shifted down a pathway that leads to stasis instead of repair. Sept. 06, 2018 Multidisciplinary care and smooth transitions for children with congenital heart disease State-of-the-art echocardiography and expertise in complex cardiac conditions help Mayo specialists diagnose and treat patients with congenital heart disease. For patients who need heart transplantation, a Mayo protocol[...] Aug. 22, 2018 Mayo Clinic launches Cardiac Sarcoidosis Clinic Specialists at Mayo Clinic's Cardiac Sarcoidosis (CS) Clinic collaborate to provide innovative approaches to the diagnosis and management of patients with suspected or clinically definite cardiac sarcoidosis. Resea[...] Aug. 22, 2018 CABANA trial results announced at Heart Rhythm Society scientific sessions: The neutral trial that wasn't neutral The CABANA trial demonstrated that ablation is an acceptable treatment strategy with low procedural risks even in treating atrial fibrillation (AF) in patients with higher underlying risk. May 04, 2018 Stroke reduction in nonvalvular atrial fibrillation with the left atrial appendage closure device: an update Left atrial occlusion devices provide a treatment option for patients at significant risk of thromboembolic stroke for whom long-term anticoagulation is either contraindicated or felt to be suboptimal. Feb. 05, 2018 Getting to the heart of sleep Explore the interplay between sleep, sleep cycle and the heart's recharging system. Obstructive sleep apnea is a strong predictor of sudden cardiac death. The key measure may be blood oxygen levels during episodes. Jan. 25, 2018 Using Statin Choice Decision-Aid tool and laboratory testing to reduce cardiac risk The Mayo Clinic Statin Choice Decision-Aid tool helps clinicians have meaningful conversations with their patients about whether they should use statins to reduce their risk of cardiovascular disease. Jan. 23, 2018 Pediatric cardiogenic shock: What is the role of medical and mechanical circulatory support? Pediatric cardiogenic shock is a nonspecific and challenging clinical scenario of decompensated heart failure and impending cardiovascular collapse. Prompt identification, evaluation and treatment of cardiogenic shock c[...] Jan. 20, 2018 Ceramides: A class of lipids with links to heart disease The pathophysiology of atherosclerosis is a complex intersection of dyslipidemia, inflammation, endothelial dysfunction and platelet activation. Recent data supports causal associations between each of these pathways an[...] Oct. 03, 2017 Pectus excavatum: Not just a cosmetic concern Untreated pectus excavatum has cosmetic as well as progressive cardiopulmonary consequences. Both open and minimally invasive operative correction by experienced surgeons in high-volume centers yield excellent results. Sept. 26, 2017 Life after Fontan palliation Mayo Clinic is currently enrolling patients who underwent Fontan procedures in the Role of Sildenafil for Fontan Associated Liver Disease (SiFALD) Study — the first study exploring alternative therapy for liver di[...] Aug. 01, 2017 Transplanted scientist develops new transplant tool Ivan Z. Nenandic, Ph.D., discusses attenuation-measuring ultrasound shearwave elastography (AMUSE), a technique that independently measures shearwave velocity and attenuation in tissue, and its application for patients [...] April 10, 2017 Do frail individuals benefit from heart surgery? Researchers comparing health, well-being, and quality of life between frail and nonfrail patients with aortic valve stenosis before and after valve replacement surgery found that individuals deemed frail before surgery [...] March 24, 2017 From apprentice to independent researcher Mayo researchers are working with nanoparticles and nanofibers to develop next-generation magnetic grafts for blood vessels and heart valves that will free patients from the need for anticoagulation medication and impro[...] March 01, 2017 Renaissance in medicine Regenerative medicine delivers specific cells or cell products to diseased tissues or organs to restore function (regeneration); uses healthy cells, tissues or organs to replace damaged ones (replacement); and boosts th[...] Dec. 05, 2016 Mayo discovery finalist for science breakthrough Researchers genetically engineered mice to kill senescent cells in response to a particular drug. Mice that ate a fat-rich diet and were dosed with the drug carried 60 percent less plaque in major arteries. Sept. 29, 2016 Team approach to valve-in-valve therapy: Innovations in treatment of bioprosthetic systemic AV valve dysfunction Mayo's structural heart team provides comprehensive care to patients who have previously undergone surgery to replace the mitral or tricuspid valve with a tissue bioprosthesis. Existing dysfunctional bioprosthetic valve[...] Sept. 26, 2016 Beat still my beating heart Researchers with the Van Cleve Cardiac Regenerative Medicine Program initiative to increase the number of available hearts for transplantation are experimenting to see if a dead heart can be awoken and damage of death m[...] Aug. 30, 2016 Heart Brain Clinic: Team approach to stroke Patients with neurological symptoms that may be due to a cardiac etiology, such as atrial fibrillation or patent foramen ovale, benefit from a team approach to treatment management. May 24, 2016 Marfan syndrome and related disorders Effective treatment has resulted in longer lives for patients with Marfan syndrome. Their care involves lifelong monitoring of cardiovascular health and management of noncardiovascular problems. May 24, 2016 The Heart Brain Clinic: Optimal team-based coordinated care The Heart Brain Clinic provides multidisciplinary evaluations to patients with neurological symptoms that may be attributable to a cardiac etiology such as patent foramen ovale or atrial fibrillation. April 01, 2016 Coronary artery calcium score: Are we doing too many or too few? Mayo clinicians who specialize in cardiovascular disease prevention believe that a coronary artery calcium score (CACS) can add valuable clinical information in selected patients. April 01, 2016 Spontaneous coronary artery dissection: Hidden in plain sight The presentation of spontaneous coronary artery dissection (SCAD) mimics other acute coronary events. At Mayo Clinic, patients with SCAD undergo comprehensive vascular imaging; 66 percent of this population has evidence[...] Jan. 28, 2016 Pediatric ventricular arrhythmia in a normal heart When a child presents with ventricular arrhythmia, specific causes warrant consideration and guide the subsequent work-up and treatment strategy. Nov. 20, 2015 Prosthetic valve thrombosis: Time is critical Anticoagulant therapy with warfarin with a goal INR of 2 to 3 is effective in treating tissue valve thrombosis in most patients. Cardiac valve replacement and the risk of thrombosis are increasingly common in aging popu[...] Nov. 20, 2015 Advancing single ventricle imaging for application of regenerative techniques in congenital heart disease Mayo specialists are developing better imaging strategies that can be used to quantify and predict ventricular dysfunction in patients with a single ventricle earlier in the disease course. Nov. 20, 2015 PCSK9 inhibition: A game changer in cholesterol management PCSK9 inhibitors fill a therapeutic niche for patients with familial hypercholesterolemia or patients with statin intolerance who are not able to achieve the desired LDL-C level with conventional treatments. May 20, 2015 Heart failure with preserved ejection fraction (HFpEF): More than diastolic dysfunction Mayo Clinic studies test acute inhaled sodium nitrite compared with placebo in people who have heart failure with preserved ejection fraction (HFpEF) and rate adaptive atrial pacing in people with HFpEF and chronotropic[...] Jan. 27, 2015 Mayo Clinic announces Carcinoid Heart Disease Clinic Carcinoid heart disease affects more than half of patients with carcinoid tumors. A new multidisciplinary clinic provides individualized review of patients to determine the degree of cardiac valve involvement and the be[...] Jan. 27, 2015 Arm ergometer provides alternative to conventional stress testing Arm ergometer exercise testing can be performed with the patient standing or seated and with or without oxygen consumption measurement. It is helpful for patients with paraplegia or symptoms that occur only during arm w[...] Nov. 21, 2014 Leadless pacing available for selected patients The Nanostim leadless pacemaker and the Micra transcatheter pacing system are implanted directly into the right ventricular apex. Nov. 21, 2014 Percutaneous therapy offers new option for treatment of mitral regurgitation Patient experience with the MitraClip device, which fixes the anterior and posterior mitral leaflets together under transesophageal echocardiographic (TEE) guidance to treat mitral regurgitation, has been favorable, wit[...] Nov. 21, 2014 Implantable loop recorders in patients with cryptogenic stroke Implantable cardiac monitoring with a subcutaneous loop recorder can detect asymptomatic, subclinical atrial fibrillation in 10 percent of patients with cryptogenic stroke at one year, but the subset of patients who wou[...] Oct. 23, 2014 Endovascular repair of complex aortic aneurysms Fenestrated and branched stent-grafts may provide a safe, effective technique for endovascular repair of aneurysms involving the visceral arteries. Studies indicate a high technical success and a low risk of complicatio[...] June 18, 2014 Pregnancy complicated by maternal congenital cardiac disease Declining cases of rheumatic heart disease and improved survival of patients with congenital heart disease have resulted in congenital defects being the most common cause of maternal heart disease affecting pregnancy in[...] June 18, 2014 Arrhythmias in adult congenital heart disease Atrial and ventricular arrhythmias are a major cause of late morbidity and mortality in patients with congenital heart disease, whose care typically requires multimodality strategies involving anti-arrhythmic drugs, det[...] April 16, 2014 Role of cardiac MRI in the assessment of cardiac amyloidosis Role of cardiac MRI in the assessment of cardiac amyloidosis — Although biopsy is still the gold standard of diagnosis for patients with suspected cardiac amyloidosis, noninvasive cardiac MRI offers superior abili[...] April 16, 2014 Investigators identify mortality risk factors in apical hypertrophic cardiomyopathy Investigators identify mortality risk factors in apical hypertrophic cardiomyopathy — Kaplan-Meier analysis of 2,662 patients with hypertrophic cardiomyopathy evaluated at Mayo Clinic indicates that predictors of [...] Sept. 05, 2013 New protocols allow for MRI in selected patients with pacemakers EFFORTLESS registry supports S-ICD efficacy and optimal lead configuration - Studies confirm the first subcutaneous implantable cardioverter-defibrillator system approved for use in the U.S. is as effective as standard [...] Profesionales médicos Cardiovascular Diseases news